Healthcare
Cencora, Inc.(COR)
Live Price
Offline$271.83
-1.90% today
1Y Change
-2.69%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $59.51B
- Revenue Growth
- +9.3%
- EPS Growth
- +5.5%
- Dividend Yield
- 0.8%
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cencora, Inc. (COR) is a Healthcare stock with a market cap of $59.51B. The stock last traded around $271.83 and down 2.7% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +9.3%, EPS growth of +5.5%, a dividend yield of 0.8%. What stands out right now is revenue +9.3%, EPS +5.5%, free cash flow +7.0% with operating margin 1.2% and ROIC 13.8%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 36.6 and price/sales 0.2. Stock Foundry combines COR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+9.3% vs +7.6% peer median
Operating Margin
Below sector median
+1.2% vs +19.4% peer median
P/E
Near sector median
36.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
Q2 2026 was reported on May 6, 2026 with an EPS surprise of +0.4%.
The operating story is still moving forward
Revenue is running at +9.3% and EPS at +5.5%, with operating margin around 1.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.8%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 May 6, 2026 | +0.4% | +1.2% | +1.2% | +7.0% |
Q1 2026 Mar 24, 2026 | -150.0% | -0.7% | -4.0% | -5.8% |
Q1 2026 Feb 25, 2026 | +168.8% | +1.0% | +1.4% | -10.5% |
Benchmark Edge
COR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
COR
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
COR Max Drawdown
-32.56%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for COR and SPY.
Company Overview
Cencora, Inc.
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 36.6
- EV/EBITDA
- 17.2
- Price/Sales
- 0.2
- Price/Book
- 31.1
Growth
- Revenue
- +9.3%
- EPS
- +5.5%
- Free Cash Flow
- +7.0%
Profitability
- Gross Margin
- 3.6%
- Operating Margin
- 1.2%
- Net Margin
- 0.5%
- ROE
- 101.4%
- ROIC
- 13.8%
Balance Sheet
- Debt/Equity
- 4.15
- Current Ratio
- 0.70
Ownership & Float
- Float
- 184.01M
- Short Interest
- 3.2%
- Insider Owned
- 4.2%
- Institutional Owned
- 98.8%
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.